BlackRock Fund Advisors’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$15K Buy
18
+1
+6% +$2.28K ﹤0.01% 3919
2016
Q3
$58K Hold
17
﹤0.01% 3738
2016
Q2
$60K Sell
17
-1
-6% -$3.94K ﹤0.01% 3784
2016
Q1
$70K Sell
18
-1
-5% -$3.8K ﹤0.01% 3743
2015
Q4
$100K Buy
19
+1
+6% +$5.13K ﹤0.01% 3731
2015
Q3
$84K Sell
18
-1
-5% -$5.97K ﹤0.01% 3735
2015
Q2
$121K Buy
19
+3
+19% +$21.3K ﹤0.01% 3695
2015
Q1
$121K Sell
16
-2
-11% -$13.9K ﹤0.01% 3590
2014
Q4
$112K Buy
18
+2
+13% +$13.9K ﹤0.01% 3600
2014
Q3
$133K Sell
16
-2
-11% -$17.4K ﹤0.01% 3588
2014
Q2
$167K Buy
18
+1
+6% +$8.93K ﹤0.01% 3546
2014
Q1
$157K Buy
17
+2
+13% +$20.8K ﹤0.01% 3519
2013
Q4
$159K Buy
15
+5
+50% +$59.9K ﹤0.01% 3493
2013
Q3
$142K Buy
10
+1
+11% +$14.8K ﹤0.01% 3489
2013
Q2
$116K Buy
+9
New +$125K ﹤0.01% 3491

Other funds holding IMNN

BlackRock Fund Advisors's IMNN Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Imunon (IMNN) stake by 5.9% in Q4 2016, buying an estimated $2.28K and bringing the position to 18 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #3919.

BlackRock Fund Advisors first reported a position in IMNN in Q2 2013 and has held it in 15 quarters since. The position peaked at $167K in Q2 2014. 23 funds tracked by Wall St. Rank hold IMNN as of Q4 2016.

  • BlackRock Fund Advisors held 18 shares of Imunon worth $15K as of Q4 2016.
  • BlackRock Fund Advisors bought 1 Imunon share in Q4 2016, an estimated $2.28K.
  • Imunon made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3919 holding.
  • BlackRock Fund Advisors first reported a position in Imunon in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Imunon position peaked at $167K in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.